Identification of a sensitive anti-erythropoietin receptor monoclonal antibody allows detection of low levels of EpoR in cells

Journal of Immunological Methods

Volumn 352, Issue 1-2, 2010, Pages 126-139

  Elliott, Steve ^a   Busse, Leigh ^a   McCaffery, Ian ^a   Rossi, John ^a   Sinclair, Angus ^a   Spahr, Chris ^a   Swift, Susan ^a   Begley, C Glenn ^a  

^a AMGEN INC   (United States)

Author keywords

Epo; Epo receptor; Erythropoietin; Monoclonal antibodies; Red blood cells; Western immunoblotting

Indexed keywords

ERYTHROPOIETIN RECEPTOR; ERYTHROPOIETIN RECEPTOR ANTIBODY; MONOCLONAL ANTIBODY; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ACCURACY; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; CANCER CELL CULTURE; CELL LYSATE; CONTROLLED STUDY; ERYTHROID CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN EXPRESSION; RECEPTOR BINDING; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CELL EXTRACTS; CELL SEPARATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROID PRECURSOR CELLS; FLOW CYTOMETRY; HELA CELLS; HUMANS; IMMUNIZATION; MICE; PEPTIDE FRAGMENTS; RABBITS; RECEPTORS, ERYTHROPOIETIN;

EID: 71749103027     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2009.10.006     Document Type: Article

References (57)

1. Acs G., Acs P., Beckwith S.M., Pitts R.L., Clements E., Wong K., and Verma A. Erythropoietin and erythropoietin receptor expression in human cancer. Cancer Research 61 (2001) 3561
2. Acs G., Zhang P.J., McGrath C.M., Acs P., McBroom J., Mohyeldin A., Liu S., Lu H., and Verma A. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression. American Journal of Pathology 162 (2003) 1789
3. Agarwal N., Gordeuk V.R., and Prchal J.T. Are erythropoietin receptors expressed in tumors? Facts and fiction-more careful studies are needed. Journal of Clinical Oncology 25 (2007) 1813
4. Ashihara E., Vannucchi A.M., Migliaccio G., and Migliaccio A.R. Growth factor receptor expression during in vitro differentiation of partially purified populations containing murine stem cells. Journal of Cellular Physiology 171 (1997) 343
5. Billia F., Barbara M., McEwen J., Trevisan M., and Iscove N.N. Resolution of pluripotential intermediates in murine hematopoietic differentiation by global complementary DNA amplification from single cells: confirmation of assignments by expression profiling of cytokine receptor transcripts. Blood 97 (2001) 2257
6. Broudy V.C., Lin N., Egrie J., de Haen C., Weiss T., Papayannopoulou T., and Adamson J.W. Identification of the receptor for erythropoietin on human and murine erythroleukemia cells and modulation by phorbol ester and dimethyl sulfoxide. Proceedings of the National Academy of Sciences of the United States of America 85 (1988) 6513
7. Broudy V.C., Lin N., Brice M., Nakamoto B., and Papayannopoulou T. Erythropoietin receptor characteristics on primary human erythroid cells. Blood 77 (1991) 2583
8. Brown W.M., Maxwell P., Graham A.N., Yakkundi A., Dunlop E.A., Shi Z., Johnston P.G., and Lappin T.R. Erythropoietin receptor expression in non-small cell lung carcinoma: a question of antibody specificity. Stem Cells 25 (2007) 718
9. D'Andrea A.D., Lodish H.F., and Wong G.G. Expression cloning of the murine erythropoietin receptor. Cell 57 (1989) 277
10. Della Ragione F., Cucciolla V., Borriello A., Oliva A., and Perrotta S. Erythropoietin receptors on cancer cells: a still open question. Journal of Clinical Oncology 25 (2007) 1812
11. Depping R., Kawakami K., Ocker H., Wagner J.M., Heringlake M., Noetzold A., Sievers H.H., and Wagner K.F. Expression of the erythropoietin receptor in human heart. Journal of Thoracic and Cardiovascular Surgery 130 (2005) 877
12. Elliott S., Lorenzini T., Yanagihara D., Chang D., and Elliott G. Activation of the erythropoietin (EPO) receptor by bivalent anti-EPO receptor antibodies. Journal of Biological Chemistry 271 (1996) 24691
13. Elliott S., Lorenzini T., Chang D., Barzilay J., and Delorme E. Mapping of the active site of recombinant human erythropoietin. Blood 89 (1997) 493
14. Elliott S., Busse L., Bass M.B., Lu H., Sarosi I., Sinclair A.M., Spahr C., Um M., Van G., and Begley C.G. Anti-Epo receptor antibodies do not predict Epo receptor expression. Blood 107 (2006) 1892
15. Elliott S., Busse L., Spahr C., and Sinclair A.M. Anti-EpoR antibodies detect a 59-kDa EpoR protein [4]. Blood 108 3 (2006) 1108 2006. Date of Publication: 01 Aug 2006. 1108
16. Fraser J.K., Lin F.K., and Berridge M.V. Expression of high affinity receptors for erythropoietin on human bone marrow cells and on the human erythroleukemic cell line, HEL. Experimental Hematology 16 (1988) 836
17. Glaspy J.A. Erythropoiesis-stimulating agents in oncology. Journal of the National Comprehensive Cancer Network 6 (2008) 565
18. Henke M., Mattern D., Pepe M., Bezay C., Weissenberger C., Werner M., and Pajonk F. Do erythropoietin receptors on cancer cells explain unexpected clinical findings?. Journal of Clinical Oncology 24 (2006) 4708
19. Hilton D.J., Watowich S.S., Murray P.J., and Lodish H.F. Increased cell surface expression and enhanced folding in the endoplasmic reticulum of a mutant erythropoietin receptor. Proceedings of the National Academy of Sciences of the United States of America 92 (1995) 190
20. Jelkmann W., Bohlius J., Hallek M., and Sytkowski A.J. The erythropoietin receptor in normal and cancer tissues. Critical Reviews in Oncology/hematology 67 (2008) 39
21. Jeong J.Y., Feldman L., Solar P., Szenajch J., and Sytkowski A.J. Characterization of erythropoietin receptor and erythropoietin expression and function in human ovarian cancer cells. International Journal of Cancer 122 (2008) 274
22. Jones S.S., D'Andrea A.D., Haines L.L., and Wong G.G. Human erythropoietin receptor: cloning, expression, and biologic characterization. Blood 76 (1990) 31
23. Juul S.E., Yachnis A.T., and Christensen R.D. Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus. Early Human Development 52 (1998) 235
24. Juul S.E., Yachnis A.T., Rojiani A.M., and Christensen R.D. Immunohistochemical localization of erythropoietin and its receptor in the developing human brain. Pediatric and Developmental Pathology 2 (1999) 148
25. Kirkeby A., van B.J., Nielsen J., Leist M., and Helboe L. Functional and immunochemical characterisation of different antibodies against the erythropoietin receptor. Journal of Neuroscience Methods 164 (2007) 50
26. Komatsu N., Yamamoto M., Fujita H., Miwa A., Hatake K., Endo T., Okano H., Katsube T., Fukumaki Y., and Sassa S. Establishment and characterization of an erythropoietin-dependent subline, UT-7/Epo, derived from human leukemia cell line, UT-7. Blood 82 (1993) 456
27. Laugsch M., Metzen E., Svensson T., Depping R., and Jelkmann W. Lack of functional erythropoietin receptors of cancer cell lines. International Journal of Cancer 122 (2008) 1005
28. Liu Z.Y., Chin K., and Noguchi C.T. Tissue specific expression of human erythropoietin receptor in transgenic mice. Developmental Biology 166 (1994) 159
29. Liu W.M., Powles T., Shamash J., Propper D., Oliver T., and Joel S. Effect of haemopoietic growth factors on cancer cell lines and their role in chemosensitivity. Oncogene 23 (2004) 981
30. Lundby C., Hellsten Y., Jensen M.B., Munch A.S., and Pilegaard H. Erythropoietin receptor in human skeletal muscle and the effects of acute and long-term injections with recombinant human erythropoietin on the skeletal muscle. Journal of Applied Physiology 104 (2008) 1154
31. Masuda S., Nagao M., Takahata K., Konishi Y., Gallyas Jr. F., Tabira T., and Sasaki R. Functional erythropoietin receptor of the cells with neural characteristics. Comparison with receptor properties of erythroid cells. Journal of Biological Chemistry 268 (1993) 11208
32. Mayeux P., Billat C., and Jacquot R. The erythropoietin receptor of rat erythroid progenitor cells. Characterization and affinity cross-linkage. Journal of Biological Chemistry 262 (1987) 13985
33. McArthur G.A., Longmore G.D., Klingler K., and Johnson G.R. Lineage-restricted recruitment of immature hematopoietic progenitor cells in response to Epo after normal hematopoietic cell transfection with EpoR. Experimental Hematology 23 (1995) 645
34. Migliaccio A.R., Migliaccio G., D'Andrea A., Baiocchi M., Crotta S., Nicolis S., Ottolenghi S., and Adamson J.W. Response to erythropoietin in erythroid subclones of the factor-dependent cell line 32D is determined by translocation of the erythropoietin receptor to the cell surface. Proceedings of the National Academy of Sciences of the United States of America 88 (1991) 11086
35. Miller C.P., lowe K.A., Valliant-Saunders K., Kaiser J.F., Mattern D., Urban N., Henke M., and Blau C.A. Evaluating erythropoietin-associated tumor progression using archival tissues from a phase III clinical trial. Stem Cells 27 (2009) 2353
36. Neumann D., Wikstrom L., Watowich S.S., and Lodish H.F. Intermediates in degradation of the erythropoietin receptor accumulate and are degraded in lysosomes. Journal of Biological Chemistry 268 (1993) 13639
37. Nowrousian M.R., Dunst J., and Vaupel P. Erythropoiesis-stimulating agents: favorable safety profile when used as indicated. Strahlentherapie und Onkologie 184 (2008) 121
38. Ogilvie M., Yu X., Nicolas-Metral V., Pulido S.M., Liu C., Ruegg U.T., and Noguchi C.T. Erythropoietin stimulates proliferation and interferes with differentiation of myoblasts. Journal of Biological Chemistry 275 (2000) 39754
39. Papayannopoulou T., Nakamoto B., Kurachi S., Tweeddale M., and Messner H. Surface antigenic profile and globin phenotype of two new human erythroleukemia lines: characterization and interpretations. Blood 72 (1988) 1029
40. Parsa C.J., Matsumoto A., Kim J., Riel R.U., Pascal L.S., Walton G.B., Thompson R.B., Petrofski J.A., Annex B.H., Stamler J.S., and Koch W.J. A novel protective effect of erythropoietin in the infarcted heart. Journal of Clinical Investigation 112 (2003) 999
41. Saintigny P., Besse B., Callard P., Vergnaud A.C., Czernichow S., Colombat M., Girard P., Validire P., Breau J.L., Bernaudin J.F., and Soria J.C. Erythropoietin and erythropoietin receptor coexpression is associated with poor survival in stage I non-small cell lung cancer. Clinical Cancer Research 13 (2007) 4825
42. Sawada K., Krantz S.B., Kans J.S., Dessypris E.N., Sawyer S., Glick A.D., and Civin C.I. Purification of human erythroid colony-forming units and demonstration of specific binding of erythropoietin. Journal of Clinical Investigation 80 (1987) 357
43. Sawada K., Krantz S.B., Sawyer S.T., and Civin C.I. Quantitation of specific binding of erythropoietin to human erythroid colony-forming cells. Journal of Cellular Physiology 137 (1988) 337
44. Sawada K., Krantz S.B., Dai C.H., Koury S.T., Horn S.T., Glick A.D., and Civin C.I. Purification of human blood burst-forming units-erythroid and demonstration of the evolution of erythropoietin receptors. Journal of Cellular Physiology 142 (1990) 219
45. Shevchenko, A., Tomas, H., Havlis, J., Olsen, J.V., Mann, M., 2006. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nature Protocols 1, 2856.
46. Shinjo K., Takeshita A., Higuchi M., Ohnishi K., and Ohno R. Erythropoietin receptor expression on human bone marrow erythroid precursor cells by a newly-devised quantitative flow-cytometric assay. British Journal Haematology 96 (1997) 551
47. Sinclair A.M., Todd M.D., Forsythe K., Knox S.J., Elliott S., and Begley C.G. Expression and function of erythropoietin receptors in tumors: implications for the use of erythropoiesis-stimulating agents in cancer patients. Cancer 110 (2007) 477
48. Sinclair A.M., Rogers N., Busse L., Archibeque I., Brown W., Kassner P.D., Watson J.E.V., Arnold G.E., Nguyen K.C.Q., Powers S., and Elliott S. Erythropoietin receptor transcription is neither elevated nor predictive of surface expression in human tumour cells. British Journal of Cancer 98 (2008) 1059
49. Siren A.L., Fratelli M., Brines M., Goemans C., Casagrande S., Lewczuk P., Keenan S., Gleiter C., Pasquali C., Capobianco A., Mennini T., Heumann R., Cerami A., Ehrenreich H., and Ghezzi P. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proceedings of the National Academy of Sciences of the United States of America 98 (2001) 4044
50. Strous G.J., van K.P., van M.G., Rijnboutt S., and Stoorvogel W. Differential effects of brefeldin A on transport of secretory and lysosomal proteins. Journal of Biological Chemistry 268 (1993) 2341
51. Sturiale A., Campo S., Crasci E., Coppolino G., Bolignano D., Grasso G., and Buemi M. Erythropoietin and its lost receptor. Nephrology, Dialysis, Transplantation 22 (2007) 1484
52. Supino-Rosin L., Yoshimura A., Altaratz H., and Neumann D. A cytosolic domain of the erythropoietin receptor contributes to endoplasmic reticulum-associated degradation. European Journal of Biochemistry 263 (1999) 410
53. Westenfelder C., and Baranowski R.L. Erythropoietin stimulates proliferation of human renal carcinoma cells. Kidney International 58 (2000) 647
54. Wickrema A., Krantz S.B., Winkelmann J.C., and Bondurant M.C. Differentiation and erythropoietin receptor gene expression in human erythroid progenitor cells. Blood 80 (1992) 1940
55. Winkelmann J.C., Penny L.A., Deaven L.L., Forget B.G., and Jenkins R.B. The gene for the human erythropoietin receptor: analysis of the coding sequence and assignment to chromosome 19p. Blood 76 (1990) 24
56. Wognum A.W., Lansdorp P.M., Humphries R.K., and Krystal G. Detection and isolation of the erythropoietin receptor using biotinylated erythropoietin. Blood 76 (1990) 697
57. Yasuda, Y., Fujita, Y., Matsuo, T., Koinuma, S., Hara, S., Tazaki, A., Onozaki, M., Hashimoto, M., Musha, T., Ogawa, K., Fujita, H., Nakamura, Y., Shiozaki, H., Utsumi, H., 2003. Erythropoietin regulates tumour growth of human malignancies. Carcinogenesis. 24(6):1021-9, 24, 1021.